Literature DB >> 17326125

Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.

Joon Seong Park1, Dong Sup Yoon, Kyung Sik Kim, Jin Sub Choi, Woo Jung Lee, Hoon Sang Chi, Byong Ro Kim.   

Abstract

BACKGROUND: Carcinoma of the ampulla of Vater has a relatively higher resection rate, lower recurrence rate, and more favorable prognosis than other malignant tumors of the periampullary region. Because of the relative low incidence of carcinoma of the ampulla of Vater, there have been few reports on the patterns and risk factors of recurrence after curative resection. The aim of this study was to evaluate the patterns and risk factors of recurrence after curative resection of ampulla of Vater carcinoma.
MATERIALS AND METHODS: Between January 1992 and December 2002, 102 patients received radical resection for ampulla of Vater carcinoma at Yonsei University Medical Center. Fifteen patients were excluded because of incomplete clinicopathologic data. Finally, 87 patients were reviewed and analyzed to assess predictors of tumor recurrence.
RESULTS: Among the 87 patients, 37 patients (42.5%) experienced recurrent disease. The mean length of time to recurrence was 29.3 +/- 35.3 months, and the most common sites of recurrence were the intra-abdominal organs: liver and loco-regional lymph nodes. The patients were divided into two groups: early recurrence (<or=18 months) and late recurrence (>18 months). In the early recurrence group, ulcer formation tumors and poorly differentiated tumors were more common in comparison with the late recurrence group. Lymph node metastasis was identified as an independent factor of tumor recurrence after curative resection for ampulla of Vater carcinoma.
CONCLUSION: Lymph node metastasis is the most important risk factor for recurrence after a curative resection. Also, the fact that a higher probability of recurrence is anticipated in cases of ulcer formation and poorly differentiated tumors, there exists a need for a close-up follow-up program. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17326125     DOI: 10.1002/jso.20665

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  29 in total

1.  Is local resection adequate for T1 stage ampullary cancer?

Authors:  Albert Amini; John T Miura; Thejus T Jayakrishnan; Fabian M Johnston; Susan Tsai; Kathleen K Christians; T Clark Gamblin; Kiran K Turaga
Journal:  HPB (Oxford)       Date:  2014-11-14       Impact factor: 3.647

2.  Pancreas-sparing duodenectomy with regional lymph node dissection for early-stage ampullary carcinoma: A case control study using propensity scoring methods.

Authors:  Bin Liu; Jing Li; Yong-Jiu Zhang; Lu-Nan Yan; Sheng-Yi You; Wan-Yee Lau; Hao-Ran Sun; Shi-Yan Yan; Zhi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

3.  Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.

Authors:  Bhanu Jayanand Sunil; Ramakrishnan A Seshadri; S Gouthaman; Rama Ranganathan
Journal:  J Gastrointest Cancer       Date:  2017-03

4.  Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival.

Authors:  Stefano Partelli; Stefano Crippa; Paola Capelli; Anna Neri; Claudio Bassi; Giuseppe Zamboni; Giuliano Barugola; Massimo Falconi
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

5.  Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Authors:  Adriana Romiti; Viola Barucca; Angelo Zullo; Ida Sarcina; Roberta Di Rocco; Chiara D'Antonio; Marco Latorre; Paolo Marchetti
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

6.  Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.

Authors:  Cosimo Sperti; Claudio Pasquali; Sergio Bissoli; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2009-09-24       Impact factor: 3.452

7.  Signet-ring cell carcinoma of the ampulla of Vater: report of a case.

Authors:  Tomotaka Akatsu; Koichi Aiura; Shin Takahashi; Kaori Kameyama; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

8.  Metastatic adenocarcinoma of parotid gland originating from the ampulla of vater: case report and review of the literature.

Authors:  Despina Spyropoulou; Vassilios Vassiliou; Vassiliki Tzelepi; Maria Kardari; Athanassios C Tsamandas; Dimitrios Kardamakis
Journal:  J Gastrointest Cancer       Date:  2008-11-19

9.  Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection.

Authors:  Jf Feng; Xm Zhou; Wm Mao
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

10.  Transduodenal Ampullectomy for the Treatment of Early-Stage Ampulla of Vater Cancer.

Authors:  Huisong Lee; Jin Young Park; Wooil Kwon; Jin Seok Heo; Dong Wook Choi; Seong Ho Choi
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.